AMINOSYN RF INJECTION
AMINOSYN RF INJECTION
Discontinued
DIN Number
00640131
Drug Class
Human
Market Date
Dec 31, 1986
Company
HC
hospira healthcare ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number00640131
AIG Number1016903001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05BA01 AMINO ACIDS
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification40:20.00
Health Canada Classification
ACTIVE INGREDIENTS (10)
ARGININEActive
Strength: 600 MG / 100 ML
Monograph: ARGININE
HISTIDINEActive
Strength: 429 MG / 100 ML
Monograph: HISTIDINE
ISOLEUCINEActive
Strength: 462 MG / 100 ML
Monograph: ISOLEUCINE
LEUCINEActive
Strength: 726 MG / 100 ML
Monograph: LEUCINE
LYSINE (LYSINE ACETATE)Active
Strength: 535 MG / 100 ML
Monograph: LYSINE (LYSINE ACETATE)
METHIONINEActive
Strength: 726 MG / 100 ML
Monograph: METHIONINE
PHENYLALANINEActive
Strength: 726 MG / 100 ML
Monograph: PHENYLALANINE
THREONINEActive
Strength: 330 MG / 100 ML
Monograph: THREONINE
TRYPTOPHANActive
Strength: 165 MG / 100 ML
Monograph: TRYPTOPHAN
VALINEActive
Strength: 528 MG / 100 ML
Monograph: VALINE